We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -4.17% | 1.15 | 1.10 | 1.20 | 1.20 | 1.15 | 1.20 | 216,341 | 08:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.29 | 1.56M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2020 20:45 | BROKERS name aim top picks - | postme | |
29/9/2020 20:35 | Value smashes piggy AGAIN lol | notknowing | |
29/9/2020 19:47 | I m optimistic about q4 ,I double my investment this week .by Xmas time I am expecting 14p min .Dyor | tmmalik | |
29/9/2020 18:18 | Woo hoo a E365m result for our client Merck KGaA today Wonder how they might spend their winnings on R&D and their partners ? Darmstadt, September 29, 2020. In the United States Merck KGaA's subsidiary EMD Serono, Inc. (Merck) is involved in a US patent dispute with Biogen Inc., United States (Biogen). Biogen sued Merck for damages in connection with a patent infringement caused by Merck's product Rebif before the U.S. District Court New Jersey, Newark. Merck defended itself against the allegations and brought a countersuit claiming that Biogen's patent is invalid. In February 2018 a jury declared Biogen's patent invalid vis-à-vis Merck. The jury verdict was overturned by the District Court Judge, who upheld the validity of Biogen's patent. Merck filed a complaint with the U.S. Court of Appeals for the Federal Circuit against this ruling. On 28 September 2020 the U.S. Court of Appeals for the Federal Circuit set aside the decision of the District Court Judge, invalidated Biogen's patent and instructed the District Court to reinstate the jury verdict. Therefore, Merck KGaA has decided today to reverse the provisions for the patent dispute proceedings in the amount of EUR 365 million. Thereof, up to a mid to high double-digit million amount might be booked into the financial result. Merck KGaA will adjust its forecasts accordingly as part of its regular financial reporting | the stigologist | |
29/9/2020 17:05 | How you feeling stig,foolish comes to mind. | albert3591 | |
29/9/2020 16:20 | A lot of unhappy people tomorrow I feel. | albert3591 | |
29/9/2020 16:07 | Looks like no ones falling for the ramps now,even stiggy has given up. | albert3591 | |
29/9/2020 14:34 | Stig They only time PYC did anything was a few years ago when the E Cig chap up here in Accrington pumped the hell out of it and added a few quid to his millions ha. | 412069 | |
29/9/2020 14:22 | PFC and CPI looking good Maddie. | notknowing |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions